Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Carlos Pollan
38 years of experience • 435+ treatments performed
Clinic is certified :
Larynx cancer treatment cost in Spain typically starts with essential diagnostics like a PET/CT scan ranging from $1,300 to $1,800. Primary surgical interventions such as a laryngectomy run from $18,000 to $30,000, while laser surgery for laryngeal cancer costs between $12,000 and $16,000. Total expenses depend on the tumor stage and chosen technology. Patients often find 30-50% savings compared to US healthcare prices. Barcelona and Madrid remain the premier destinations for oncology.
Typical Larynx Cancer Treatment Costs in Spain
Bookimed Expert Insight: Early-stage patients should prioritize centers offering organ-preserving laser surgeries. Hospital Quiron Barcelona provides advanced robotized surgery and PET-CT staging, supporting 40,000 patients annually. For complex cases, Clinica Universidad de Navarra offers JCI-accredited care with high success rates. Patients seeking innovative research may find value at Quironsalud Madrid, which conducts active cancer clinical trials.
| Turkey | Austria | Spain | |
| Throat cancer operation | from $9,000 | from $30,000 | from $22,500 |
| Proton-beam therapy | from $70,000 | from $80,000 | from $25,322 |
| Laser surgery for laryngeal cancer | from $7,000 | from $15,000 | from $12,000 |
| Chemotherapy for larynx cancer | from $5,000 | from $12,000 | from $4,000 |
| Laryngectomy | from $8,000 | from $25,000 | from $18,000 |
Dr. López-Ibor specializes in pediatric hematology and oncology, with over 32 years of experience of experience treating bone and brain tumors.
Dr. Luis Madero is a pediatric oncologist with 37 years of experience in treating blood disorders, bone marrow transplant, ablation therapy, and other diseases. He is a member of several associations and has extensive experience in his field.
Dr. Enriqueta Felip is an expert in thoracic oncology. She specializes in lung cancer care and clinical trials. She earned her medical degree and PhD from UAB. Dr. Felip has led research on improving chemotherapy, developing new therapies, using immunotherapy, and understanding resistance to targeted treatments.
She served as a board member of the IASLC from 2017 to 2021 and was Vice-President of SEOM from 2019 to 2021. In 2015, she received the first ESMO Women for Oncology Award. Dr. Felip has written many peer-reviewed articles and book chapters. She is known for her leadership in international oncology societies and clinical research.